Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Receivables - Other (2021 - 2025)

Historic Receivables - Other for Amphastar Pharmaceuticals (AMPH) over the last 5 years, with Q3 2025 value amounting to $500000.0.

  • Amphastar Pharmaceuticals' Receivables - Other rose 2500.0% to $500000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $500000.0, marking a year-over-year increase of 2500.0%. This contributed to the annual value of $200000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Amphastar Pharmaceuticals reported Receivables - Other of $500000.0 as of Q3 2025, which was up 2500.0% from $500000.0 recorded in Q2 2025.
  • Amphastar Pharmaceuticals' Receivables - Other's 5-year high stood at $2.5 million during Q3 2021, with a 5-year trough of $200000.0 in Q3 2022.
  • Over the past 5 years, Amphastar Pharmaceuticals' median Receivables - Other value was $300000.0 (recorded in 2024), while the average stood at $518181.8.
  • Its Receivables - Other has fluctuated over the past 5 years, first plummeted by 9200.0% in 2022, then soared by 6666.67% in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Receivables - Other (Quarter) stood at $2.5 million in 2021, then crashed by 84.0% to $400000.0 in 2022, then tumbled by 50.0% to $200000.0 in 2023, then changed by 0.0% to $200000.0 in 2024, then skyrocketed by 150.0% to $500000.0 in 2025.
  • Its Receivables - Other stands at $500000.0 for Q3 2025, versus $500000.0 for Q2 2025 and $200000.0 for Q1 2025.